CLINICAL TRIALS PROFILE FOR OMIDRIA
✉ Email this page to a colleague
All Clinical Trials for omidria
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02895035 ↗ | Comparison of Epinephrine and Phenylephrine/Ketorolac With Regards to Pupil Size | Terminated | Milton S. Hershey Medical Center | Phase 4 | 2016-09-01 | The objective of this study is to compare the maintenance of intraoperative mydriasis during cataract surgery between two drugs: epinephrine, which has routinely been used for decades, and Omidria, a newly FDA approved combination drug of phenylephrine and ketorolac. Patients undergoing cataract surgery that are enrolled in the trial will randomly receive one of the drugs in one eye, and the other eye will receive the drug during the subsequent cataract surgery. |
| NCT03864133 ↗ | No Drop Post-Op Cataract Surgery | Completed | Omeros Corporation | Phase 4 | 2019-07-08 | This study evaluates the effect of Intraocular Phenylephrine/Ketorolac Infusion on Retinal Thickness and Macular Edema in Cataract Surgery. Participants will receive infusions of Phenylephrine/Ketorolac during surgery instead of receiving topical NSAID drops pre and post operatively. |
| NCT03864133 ↗ | No Drop Post-Op Cataract Surgery | Completed | Wake Forest University Health Sciences | Phase 4 | 2019-07-08 | This study evaluates the effect of Intraocular Phenylephrine/Ketorolac Infusion on Retinal Thickness and Macular Edema in Cataract Surgery. Participants will receive infusions of Phenylephrine/Ketorolac during surgery instead of receiving topical NSAID drops pre and post operatively. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for omidria
Condition Name
Clinical Trial Locations for omidria
Trials by Country
Clinical Trial Progress for omidria
Clinical Trial Phase
Clinical Trial Sponsors for omidria
Sponsor Name
